Choksi Laboratories Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials and compliance.
CIN L85195MP1993PLC007471 Incorporated 29 January 1993 ROC Gwalior HQ Indore, Madhya Pradesh, India
Active Listed - BSE: 526546 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹46.01 Cr
▲ 10.11% YoY
EBITDA · FY 2026
₹12.35 Cr
▲ 9.25% YoY
Net profit · FY 2026
₹1.96 Cr
▲ 28.95% YoY
Authorised capital
₹15 Cr
Registered with MCA
Paid-up capital
₹6.97 Cr
Issued & subscribed
Open charges
₹31.69 Cr
Satisfied ₹47.52 Cr
Company age
33 yrs
Est. 1993
Employees · EPFO
318
Latest available

About Choksi Laboratories Limited

Data last updated: 06 January 2026

Choksi Laboratories Limited is a public limited company based in Indore, Madhya Pradesh, India. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 29 January 1993, the company has been in operation for over 33 years.

Registered with ROC Gwalior under CIN L85195MP1993PLC007471. Listed on BSE: 526546.

Capital: an authorised share capital of ₹15 Cr and a paid-up capital of ₹6.97 Cr. Formerly known as Choksi Analytical Services Limited. It is led by directors including Meenaxi Patidar and Raghmendra Singh.

Last AGM: 16 September 2025. Financial statements filed for year ended 31 March 2025. Office: 1 Near Tulsiyana Industrial Park, Indore, Madhya Pradesh.

As per the financials filed for FY 2025, the company reported a revenue of ₹41.85 Cr, a growth of 14% compared to the previous year.

The company has a workforce of approximately 318 employees as per the latest available data.

The company is associated with 1 brand - Choksi Laboratories. As per MCA filings, the company has open charges of ₹31.69 Cr and satisfied charges of ₹47.52 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website choksilab.com.

Company Details of Choksi Laboratories Limited
CIN L85195MP1993PLC007471
Registration Number 007471
Incorporation Date 29 January 1993
ROC Gwalior
Listing Status Listed (BSE: 526546)
Company Status Active
Date of Last AGM 16 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
  • Social Media
  • Registered Address
    Survey No 9/1 Near Tulsiyana Industrial Park Gram Kum, Erdi, Indore, Madhya Pradesh, India – 452010
  • Industry
    Pharma, Pharma Contract R&D
Company report
Choksi Laboratories Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Choksi Laboratories Limited report

Financials, compliance, directors, charges, ownership and filings for Choksi Laboratories Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Choksi Laboratories Limited

Choksi Laboratories Limited operates one associated brand: Choksi Laboratories. These brands represent Choksi Laboratories Limited's diversified market presence and brand portfolio.

Brand Description Website
Laboratory services for pharmaceutical and food analysis are provided. choksilab.com

Business Activity of Choksi Laboratories Limited

Choksi Laboratories Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including architecture, engineering activities, technical testing and analysis activities.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
M Professional, Scientific and Technical M4 Architecture, engineering activities, technical testing and analysis activities *********

Auditor Details of Choksi Laboratories Limited

Choksi Laboratories Limited is audited by M/s Prateek Jain & Co. (ICAI peer reviewed, certificate valid till 2028-03-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
M/s Prateek Jain & Co. (ICAI peer reviewed, certificate valid till 2028-03-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Choksi Laboratories Limited

Choksi Laboratories Limited is currently managed by 10 directors, with 16 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Meenaxi Patidar Director 05 Jul 2023 3 Years 0 Months Current
Raghmendra Singh Director 13 Aug 2022 3 Years 10 Months Current
Prachi Mantri Director 03 Feb 2024 2 Years 5 Months Current
Abha Shastri Director 01 Apr 2024 2 Years 3 Months Current
Vyangesh Choksi Whole-Time Director 01 Aug 2009 16 Years 11 Months Current
Himika Choksi Whole-Time Director 01 Mar 2017 9 Years 4 Months Current
Showing 6 of 10 current directors. View all directors

Financials of Choksi Laboratories Limited FY 2026 filings available

Choksi Laboratories Limited reported revenue of ₹46.01 Cr (up 10.11% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2026
₹46.01 Cr ▲ 10.11%
Profit · FY 2026
₹1.96 Cr ▲ 28.95%
EBITDA · FY 2026
₹12.35 Cr ▲ 9.25%
Revenue₹ Cr · Standalone0204060FY 2019: ₹34 Cr33.7FY 2019FY 2020: ₹28 Cr · -16.6% YoY28.2-16.6%FY 2020FY 2021: ₹26 Cr · -8.8% YoY25.7-8.8%FY 2021FY 2022: ₹30 Cr · +16.9% YoY30+16.9%FY 2022FY 2023: ₹34 Cr · +14.6% YoY34.4+14.6%FY 2023FY 2024: ₹37 Cr · +6.5% YoY36.7+6.5%FY 2024FY 2025: ₹42 Cr · +13.9% YoY41.8+13.9%FY 2025FY 2026: ₹46 Cr · +10.1% YoY46+10.1%FY 2026
Net Profit₹ Cr · Standalone-4-2024FY 2019: ₹2 Cr1.6FY 2019FY 2020: ₹4 Cr (loss) · -342.8% YoY-3.9FY 2020FY 2021: ₹3 Cr (loss) · +32.9% YoY-2.6FY 2021FY 2022: ₹0 Cr · +107.9% YoY0.2+107.9%FY 2022FY 2023: ₹3 Cr · +1450.7% YoY3.2+1450.7%FY 2023FY 2024: ₹1 Cr · -65.4% YoY1.1-65.4%FY 2024FY 2025: ₹2 Cr · +37.3% YoY1.5+37.3%FY 2025FY 2026: ₹2 Cr · +29% YoY2+29%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year051015Q1'25: ₹11 Cr10.7Q1'25Q2'25: ₹9 Cr9.3Q2'25Q3'25: ₹10 Cr10.4Q3'25Q4'25: ₹11 Cr11.4Q4'25Q1'26: ₹11 Cr · +4.7% YoY11.2+4.7%Q1'26Q2'26: ₹11 Cr · +20% YoY11.1+20%Q2'26Q3'26: ₹11 Cr · +4.2% YoY10.8+4.2%Q3'26Q4'26: ₹13 Cr · +12.5% YoY12.8+12.5%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹46.01 Cr ₹41.78 Cr ₹36.7 Cr ₹34.44 Cr ₹30.04 Cr ₹25.69 Cr ₹28.16 Cr ₹33.75 Cr
Other Income ₹21.34 Lakh ₹6.71 Lakh ₹16.41 Lakh ₹21.7 Lakh ₹11.96 Lakh ₹48.82 Lakh ₹32.88 Lakh ₹24.57 Lakh
Total Income ₹46.22 Cr ₹41.85 Cr ₹36.86 Cr ₹34.66 Cr ₹30.16 Cr ₹26.18 Cr ₹28.49 Cr ₹33.99 Cr
Cost of Materials Consumed ₹3.44 Cr ₹3.1 Cr ₹2.56 Cr ₹2.21 Cr ₹1.98 Cr ₹2.57 Cr ₹3.24 Cr ₹3.95 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹18.62 Cr ₹16.98 Cr ₹14.55 Cr ₹13.38 Cr ₹12.01 Cr ₹11.5 Cr ₹12.84 Cr ₹12.65 Cr
Finance Costs ₹2.82 Cr ₹2.65 Cr ₹3.01 Cr ₹3.49 Cr ₹3.21 Cr ₹2.82 Cr ₹1.89 Cr ₹1.54 Cr
Depreciation & Amortisation ₹7.09 Cr ₹6.5 Cr ₹5.71 Cr ₹5.5 Cr ₹5.43 Cr ₹4.6 Cr ₹4.56 Cr ₹3.68 Cr
Other Expenses ₹11.81 Cr ₹10.47 Cr ₹9.37 Cr ₹8.61 Cr ₹7.17 Cr ₹7.5 Cr ₹9.24 Cr ₹9.89 Cr
Total Expenses ₹43.78 Cr ₹39.7 Cr ₹35.2 Cr ₹33.19 Cr ₹29.79 Cr ₹28.98 Cr ₹31.77 Cr ₹31.7 Cr
Profit Before Exceptional Items & Tax ₹2.44 Cr ₹2.15 Cr ₹1.66 Cr ₹1.47 Cr ₹36.7 Lakh -₹2.81 Cr -₹3.28 Cr ₹2.29 Cr
Exceptional Items ₹75.3 Lakh ₹0 ₹0 ₹2.26 Cr ₹0 ₹0 -₹2.43 Cr ₹0
Profit Before Tax ₹3.19 Cr ₹2.15 Cr ₹1.66 Cr ₹3.72 Cr ₹36.7 Lakh -₹2.81 Cr -₹5.71 Cr ₹2.29 Cr
Total Tax Expense ₹1.23 Cr ₹63 Lakh ₹55.34 Lakh ₹51.14 Lakh ₹16 Lakh -₹20.05 Lakh -₹1.83 Cr ₹69.45 Lakh
Net Profit ₹1.96 Cr ₹1.52 Cr ₹1.11 Cr ₹3.21 Cr ₹20.7 Lakh -₹2.61 Cr -₹3.88 Cr ₹1.6 Cr
Other Comprehensive Income ₹63,000 -₹15.35 Lakh -₹76,000 ₹33,000 -₹5.06 Lakh ₹13.35 Lakh ₹15.9 Lakh ₹88,000
Total Comprehensive Income ₹1.97 Cr ₹1.37 Cr ₹1.1 Cr ₹3.21 Cr ₹15.64 Lakh -₹2.47 Cr -₹3.73 Cr ₹1.61 Cr
EBITDA (computed) ₹12.35 Cr ₹11.3 Cr ₹10.38 Cr ₹10.46 Cr ₹9 Cr ₹4.61 Cr ₹3.17 Cr ₹7.51 Cr
Basic EPS ₹2.82 ₹2.19 ₹1.59 ₹4.61 ₹0.30 ₹-3.74 ₹-5.58 ₹2.30
Diluted EPS ₹2.82 ₹2.19 ₹1.59 ₹4.61 ₹0.30 ₹-3.74 ₹-5.58 ₹2.30
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹71.92 Cr ₹65.33 Cr ₹61.95 Cr ₹60.36 Cr ₹64.47 Cr ₹66.38 Cr ₹65.01 Cr ₹55.35 Cr
Non-current Assets ₹53.05 Cr ₹49.01 Cr ₹47.38 Cr ₹46.42 Cr ₹50.41 Cr ₹53.35 Cr ₹48.46 Cr ₹39.04 Cr
Current Assets ₹18.87 Cr ₹16.32 Cr ₹14.57 Cr ₹13.95 Cr ₹14.06 Cr ₹13.03 Cr ₹16.54 Cr ₹16.3 Cr
Property, Plant & Equipment ₹47.42 Cr ₹46.35 Cr ₹42.17 Cr ₹43.05 Cr ₹44.19 Cr ₹47.37 Cr ₹31 Cr ₹34.51 Cr
Inventories ₹23.67 Lakh ₹55.71 Lakh ₹36.37 Lakh ₹20.9 Lakh ₹25.04 Lakh ₹11.2 Lakh ₹17.7 Lakh ₹40.55 Lakh
Trade Receivables ₹14.73 Cr ₹11.27 Cr ₹10.39 Cr ₹10.65 Cr ₹10.29 Cr ₹8.16 Cr ₹6.99 Cr ₹8.79 Cr
Cash & Equivalents ₹20.67 Lakh ₹61.22 Lakh ₹65.69 Lakh ₹33.75 Lakh ₹40.71 Lakh ₹30.61 Lakh ₹42.56 Lakh ₹6.96 Lakh
Equity (Net Worth) ₹25.58 Cr ₹23.6 Cr ₹22.21 Cr ₹21.11 Cr ₹17.9 Cr ₹17.75 Cr ₹20.22 Cr ₹24.01 Cr
Equity Share Capital ₹6.97 Cr ₹6.97 Cr ₹6.97 Cr ₹6.97 Cr ₹6.97 Cr ₹6.97 Cr ₹6.97 Cr ₹6.97 Cr
Borrowings (Non-current) ₹17.81 Cr ₹15.23 Cr ₹18 Cr ₹23.61 Cr ₹27.54 Cr ₹28.82 Cr ₹27.36 Cr ₹14 Cr
Borrowings (Current) ₹12.37 Cr ₹12.84 Cr ₹11.28 Cr ₹6.74 Cr ₹7.22 Cr ₹2.48 Cr ₹2.49 Cr ₹1.12 Cr
Total Debt (computed) ₹30.18 Cr ₹28.07 Cr ₹29.27 Cr ₹30.35 Cr ₹34.76 Cr ₹31.29 Cr ₹29.85 Cr ₹15.12 Cr
Current Liabilities ₹23.09 Cr ₹23.88 Cr ₹18.85 Cr ₹12.51 Cr ₹15.57 Cr ₹16.22 Cr ₹14.48 Cr ₹13.48 Cr
Total Liabilities ₹46.35 Cr ₹41.73 Cr ₹39.74 Cr ₹39.26 Cr ₹46.56 Cr ₹48.63 Cr ₹44.79 Cr ₹31.34 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹8.61 Cr ₹11.78 Cr ₹11.55 Cr ₹8.25 Cr ₹7.88 Cr
Investing Cash Flow -₹7.82 Cr -₹7.62 Cr -₹6.84 Cr -₹70.84 Lakh -₹2.71 Cr
Financing Cash Flow -₹1.2 Cr -₹4.2 Cr -₹4.39 Cr -₹7.62 Cr -₹5.07 Cr
Capital Expenditure ₹7.58 Cr ₹7.44 Cr ₹4.34 Cr ₹3.93 Cr ₹98.28 Lakh
Free Cash Flow (computed) ₹1.03 Cr ₹4.34 Cr ₹7.2 Cr ₹4.32 Cr ₹6.89 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash -₹40.56 Lakh -₹4.46 Lakh ₹31.94 Lakh -₹6.96 Lakh ₹10.1 Lakh
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹12.82 Cr ₹10.82 Cr ₹11.12 Cr ₹11.24 Cr ₹11.4 Cr ₹10.38 Cr ₹9.26 Cr ₹10.74 Cr
Other Income ₹6.19 Lakh ₹13.34 Lakh ₹1.48 Lakh ₹33,000 ₹4.43 Lakh ₹84,000 ₹90,000 ₹54,000
Total Income ₹12.88 Cr ₹10.96 Cr ₹11.13 Cr ₹11.25 Cr ₹11.44 Cr ₹10.39 Cr ₹9.27 Cr ₹10.74 Cr
Cost of Materials Consumed ₹1.01 Cr ₹88.39 Lakh ₹70.9 Lakh ₹84.5 Lakh ₹80.09 Lakh ₹80.01 Lakh ₹62.09 Lakh ₹87.63 Lakh
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹4.91 Cr ₹4.54 Cr ₹4.57 Cr ₹4.59 Cr ₹4.52 Cr ₹4.39 Cr ₹4.13 Cr ₹3.94 Cr
Finance Costs ₹71.37 Lakh ₹80.81 Lakh ₹69.36 Lakh ₹60.1 Lakh ₹58.15 Lakh ₹69.15 Lakh ₹65.74 Lakh ₹71.89 Lakh
Depreciation & Amortisation ₹1.89 Cr ₹1.83 Cr ₹1.69 Cr ₹1.68 Cr ₹1.7 Cr ₹1.68 Cr ₹1.61 Cr ₹1.5 Cr
Other Expenses ₹3.26 Cr ₹2.77 Cr ₹2.91 Cr ₹2.9 Cr ₹2.58 Cr ₹2.65 Cr ₹2.15 Cr ₹3.09 Cr
Total Expenses ₹11.78 Cr ₹10.83 Cr ₹10.57 Cr ₹10.62 Cr ₹10.18 Cr ₹10.21 Cr ₹9.17 Cr ₹10.13 Cr
Profit Before Exceptional Items & Tax ₹1.1 Cr ₹12.58 Lakh ₹56.25 Lakh ₹62.74 Lakh ₹1.26 Cr ₹18.24 Lakh ₹9.65 Lakh ₹61.5 Lakh
Exceptional Items ₹0 ₹77.8 Lakh ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹1.1 Cr ₹90.38 Lakh ₹56.25 Lakh ₹62.74 Lakh ₹1.26 Cr ₹18.24 Lakh ₹9.65 Lakh ₹61.5 Lakh
Total Tax Expense ₹7.41 Lakh ₹59.34 Lakh ₹32.04 Lakh ₹24.24 Lakh ₹33.81 Lakh ₹7.66 Lakh ₹2.1 Lakh ₹19.43 Lakh
Net Profit ₹1.03 Cr ₹31.04 Lakh ₹24.21 Lakh ₹38.5 Lakh ₹92.13 Lakh ₹10.58 Lakh ₹7.55 Lakh ₹42.07 Lakh
Other Comprehensive Income -₹27.5 Lakh ₹1.97 Lakh ₹25.23 Lakh ₹93,000 -₹24.8 Lakh ₹13.07 Lakh ₹24.65 Lakh ₹5.89 Lakh
Total Comprehensive Income ₹75.18 Lakh ₹33.01 Lakh ₹49.44 Lakh ₹39.43 Lakh ₹67.33 Lakh ₹23.65 Lakh ₹32.2 Lakh ₹47.96 Lakh
EBITDA (computed) ₹3.71 Cr ₹2.77 Cr ₹2.94 Cr ₹2.9 Cr ₹3.55 Cr ₹2.55 Cr ₹2.37 Cr ₹2.84 Cr
Basic EPS ₹1.47 ₹0.45 ₹0.35 ₹0.55 ₹1.32 ₹0.15 ₹0.11 ₹0.60
Diluted EPS ₹1.47 ₹0.45 ₹0.35 ₹0.55 ₹1.32 ₹0.15 ₹0.11 ₹0.60
Latest 8 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Choksi Laboratories Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Choksi Laboratories Limited

As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 31.48%, foreign institutional investors hold 6.03%, retail and other public shareholders hold 62.49% of Choksi Laboratories Limited. The company had 4,011 shareholders on record.

Promoters: 31.48%FII (Foreign Institutional): 6.03%Retail & Others: 62.49%
Mar 2026
QUARTER
31.48% Promoters
6.03% FII (Foreign Institutional)
62.49% Retail & Others
Promoter holding - history
Now 31.48% · Mar 2026High 31.48% · Jun 2023Low 31.48% · Jun 2023
30%30.8%31.5%32.3%33%Jun 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2023: 31.48%Sep 2023: 31.48%Dec 2023: 31.48%Mar 2024: 31.48%Jun 2024: 31.48%Sep 2024: 31.48%Dec 2024: 31.48%Mar 2025: 31.48%Jun 2025: 31.48%Sep 2025: 31.48%Dec 2025: 31.48%Mar 2026: 31.48%31.48%31.48%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters31.48%31.48%31.48%31.48%31.48%31.48%
Public68.52%68.52%68.52%68.52%68.52%68.52%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024
Promoters31.48%31.48%31.48%
Public68.52%68.52%68.52%
Promoter change (YoY, %pts)+0.00+0.00-

Charges & Borrowings of Choksi Laboratories Limited

Open charges
₹31.69 Cr
Satisfied charges
₹47.52 Cr
Breakdown by lending institutions
State Bank of India₹30.87 Cr
Hdfc Bank Limited₹0.63 Cr
Uco Bank₹0.20 Cr
Latest charge details
DateLenderAmountStatus
31 May 2025 Hdfc Bank Limited ₹12.5 Lakh Open
23 Jan 2025 State Bank of India ₹6.75 Cr Open
21 May 2024 Hdfc Bank Limited ₹50 Lakh Open
10 Oct 2023 State Bank of India ₹68 Lakh Open
29 Aug 2022 Uco Bank ₹20 Lakh Open

Total charge records: 38 View all charges

Employees and EPFO Compliance at Choksi Laboratories Limited

Choksi Laboratories Limited has a workforce of 318 employees as of Mar 31, 2024.

Employee count
318
Active EPFO establishments
4
Employee growth
1.27%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Choksi Laboratories Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Choksi Laboratories Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Choksi Laboratories Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Choksi Laboratories Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Choksi Laboratories Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Choksi Laboratories Limited

MSME Payment Delays by Choksi Laboratories Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Choksi Laboratories Limited

Subsidiaries & Group Companies of Choksi Laboratories Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Choksi Laboratories Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Choksi Laboratories Limited

MCA Filings & Documents of Choksi Laboratories Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Choksi Laboratories Limited

Charges
07 Nov 2025
A charge with State Bank Of India of Rs. 15.16 Cr registered on 19 Jun 2019 with Charge ID 100271142 was modified on 07 Nov 2025.
Activity
16 Sep 2025
Choksi Laboratories Limited last Annual general meeting of members was held on 16 Sep 2025 as per latest MCA records.
Charges
29 Aug 2025
A charge registered on 29 Aug 2022 via Charge ID 100609368 with Canara Bank was fully satisfied on 29 Aug 2025.
Charges
31 May 2025
A charge with Hdfc Bank Limited amounted to Rs. 0.13 Cr with Charge ID 101113240 was registered on 31 May 2025.
Activity
31 Mar 2025
Choksi Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
23 Jan 2025
A charge with State Bank Of India amounted to Rs. 6.75 Cr with Charge ID 101052582 was registered on 23 Jan 2025.

Recent News on Choksi Laboratories Limited

Frequently Asked Questions about Choksi Laboratories Limited

Choksi Laboratories Limited is an active public limited company in the pharma sector based in Indore, Madhya Pradesh, India. It was incorporated on 29 January 1993 (33+ years old) and is registered under CIN L85195MP1993PLC007471. Listed on BSE: 526546. The company has 318 employees.

Choksi Laboratories Limited reported revenue of ₹41.85 Cr for FY 2025 (up 14.00% YoY).

The current directors of Choksi Laboratories Limited are:

The primary industry of Choksi Laboratories Limited is pharma. The company specifically operates in pharma contract r and d. The company is currently active in this sector.

Yes. Choksi Laboratories Limited is listed on BSE with code 526546.

Choksi Laboratories Limited can be reached at the registered office: Survey No 91 Near Tulsiyana Industrial Park Gram Kum, Erdi, Indore, Madhya Pradesh, India – 452010, or through the website choksilab.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available